The Food and Drug Administration granted accelerated approval to Pfizer’s therapy for treating patients with a type of blood cancer that is difficult to treat.
You are here: Home / U.S. FDA approves Pfizer’s blood cancer therapy
Market News and Views
The Food and Drug Administration granted accelerated approval to Pfizer’s therapy for treating patients with a type of blood cancer that is difficult to treat.